galantamine
UkraineDrugs containing this active substance
-
The drug is used to treat diseases of the peripheral nervous system, conditions following spinal cord injuries, cerebral palsy, neuromuscular junction disorders (e.g., myasthenia gravis), and cognitive impairments in various central nervous system diseases. It is also used to reverse the effects of muscle relaxants in anesthesiology and in cases of anticholinergic poisoning.
Form: solution for injection
Active substance Dosage galantamine 1 mg/ml ATC: N06DA04
Manufacturer: JSC "Sofarma"
-
The drug is used for the treatment of peripheral nervous system diseases, conditions following spinal cord injuries, cerebral palsy, neuromuscular junction disorders (e.g., myasthenia gravis), as well as cognitive impairments in various central nervous system diseases. It is also used to reverse the effects of muscle relaxants, in anticholinergic poisoning, and in certain surgical conditions.
Form: solution for injection
Active substance Dosage galantamine 2.5 mg/ml ATC: N06DA04
Manufacturer: JSC "Sofarma"
-
The drug is used to treat diseases of the peripheral nervous system, conditions following spinal cord injuries, cerebral palsy, neuromuscular junction disorders (e.g., myasthenia gravis), as well as to improve cognitive functions in various diseases of the central nervous system. It is also used to reverse the effects of muscle relaxants, in anticholinergic poisoning, and in physiotherapy.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N06DA04
Manufacturer: JSC "Sofarma"
-
The drug is used for the treatment of mild to moderate Alzheimer-type dementia, peripheral nervous system diseases, conditions following spinal cord injuries (e.g., after poliomyelitis), cerebral palsy, as well as neuromuscular junction disorders (myasthenia gravis, muscular dystrophy).
Form: tablets
Active substance Dosage galantamine 5 mg ATC: N06DA04
Manufacturer: JSC "Sofarma"
-
The drug is used for the treatment of mild to moderate Alzheimer's-type dementia, diseases of the peripheral nervous system, conditions following spinal cord injuries (e.g., after poliomyelitis), cerebral palsy, as well as neuromuscular junction disorders (myasthenia gravis, muscular dystrophy).
Form: tablets
Active substance Dosage galantamine 10 mg ATC: N06DA04
Manufacturer: JSC "Sofarma"